Guillem Ramis
Palma, PM, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Transthyretin is a novel innate immune effector against Gram negative bacteria.
Journal: PLoS pathogens
Published: January 30, 2026
Glioblastoma Embryonic-like Stem Cells Exhibit Immune-Evasive Phenotype.
Journal: Cancers
Published: March 25, 2022
Introducing a squaramide-based self-immolative spacer for controlled drug release.
Journal: Chemical communications (Cambridge, England)
Published: February 25, 2021
The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 25, 2019
N-(2-methyl-indol-1H-5-yl)-1-naphthalenesulfonamide: A novel reversible antimitotic agent inhibiting cancer cell motility.
Journal: Biochemical pharmacology
Published: April 25, 2016
Cell uptake and localization studies of squaramide based fluorescent probes.
Journal: Bioconjugate chemistry
Published: July 19, 2014
Cyclosquaramides as kinase inhibitors with anticancer activity.
Journal: ChemMedChem
Published: March 21, 2012
EGFR inhibition in glioma cells modulates Rho signaling to inhibit cell motility and invasion and cooperates with temozolomide to reduce cell growth.
Journal: PloS one
Published: February 10, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026